238 related articles for article (PubMed ID: 29661586)
1. Australian rubella serosurvey 2012-2013: On track for elimination?
Edirisuriya C; Beard FH; Hendry AJ; Dey A; Gidding HF; Hueston L; Dwyer DE; Wood JG; Macartney KK; McIntyre PB
Vaccine; 2018 May; 36(20):2794-2798. PubMed ID: 29661586
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
Fitter DL; Anselme R; Paluku G; Rey G; Flannery B; Tohme RA; Marston BJ; Griswold M; Boncy J; Vertefeuille JF
Vaccine; 2013 Dec; 32(1):69-73. PubMed ID: 24188751
[TBL] [Abstract][Full Text] [Related]
3. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.
Hachiya M; Vynnycky E; Mori Y; Do HT; Huynh MK; Trinh LH; Nguyen DD; Tran NAT; Hoang TT; Hoang HHT; Vo NDT; Le TH; Ichimura Y; Miyano S; Okawa S; Thandar MM; Yokobori Y; Inoue Y; Mizoue T; Takeda M; Komada K
Int J Infect Dis; 2024 Jul; 144():107053. PubMed ID: 38641317
[TBL] [Abstract][Full Text] [Related]
4. Declining measles antibodies in the era of elimination: Australia's experience.
Gidding HF; Quinn HE; Hueston L; Dwyer DE; McIntyre PB
Vaccine; 2018 Jan; 36(4):507-513. PubMed ID: 29269156
[TBL] [Abstract][Full Text] [Related]
5. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination.
Song N; Gao Z; Wood JG; Hueston L; Gilbert GL; MacIntyre CR; Quinn HE; Menzies R; McIntyre P
Vaccine; 2012 Jun; 30(27):4073-8. PubMed ID: 22554644
[TBL] [Abstract][Full Text] [Related]
6. Australian mumps serosurvey 2012-2013: any cause for concern?
Patel C; Beard F; Hendry A; Quinn H; Dey A; Macartney K; Hueston L; Dwyer DE; McIntyre P
Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829703
[TBL] [Abstract][Full Text] [Related]
7. Models of strategies for control of rubella and congenital rubella syndrome-a 40 year experience from Australia.
Gao Z; Wood JG; Burgess MA; Menzies RI; McIntyre PB; MacIntyre CR
Vaccine; 2013 Jan; 31(4):691-7. PubMed ID: 23196206
[TBL] [Abstract][Full Text] [Related]
8. [The seroprevalence of IgG antibodies against rubella (German measles) in 10-49 year-old women from Cartagena, Colombia].
Mora-García GJ; Ramos-Clason E; Mazenett E; Gómez-Camargo D
Rev Salud Publica (Bogota); 2011 Apr; 13(2):288-97. PubMed ID: 22030886
[TBL] [Abstract][Full Text] [Related]
9. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence and durability of rubella virus antibodies in a highly immunized population.
Crooke SN; Haralambieva IH; Grill DE; Ovsyannikova IG; Kennedy RB; Poland GA
Vaccine; 2019 Jun; 37(29):3876-3882. PubMed ID: 31126859
[TBL] [Abstract][Full Text] [Related]
11. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
[TBL] [Abstract][Full Text] [Related]
12. An epidemiological assessment towards elimination of rubella and congenital rubella syndrome in Singapore.
Chua YX; Ang LW; Low C; James L; Cutter JL; Goh KT
Vaccine; 2015 Jun; 33(27):3150-7. PubMed ID: 25887085
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme.
Patić A; Štrbac M; Petrović V; Milošević V; Ristić M; Hrnjaković Cvjetković I; Medić S
PLoS One; 2020; 15(1):e0227413. PubMed ID: 31929584
[TBL] [Abstract][Full Text] [Related]
14. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel.
Levine H; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Zarka S; Balicer RD
Vaccine; 2012 Nov; 30(50):7260-4. PubMed ID: 23063839
[TBL] [Abstract][Full Text] [Related]
15. Australian vaccine preventable disease epidemiological review series: rubella 2008-2012.
Chan J; Dey A; Wang H; Martin N; Beard F
Commun Dis Intell Q Rep; 2015 Mar; 39(1):E19-26. PubMed ID: 26063094
[TBL] [Abstract][Full Text] [Related]
16. Persistence of Anti-Rubella Immunoglobulin G Antibody Titers in Young Adults Involved in a Short-Term Periodic Immunization in Japan.
Sasaki H; Fukunaga T; Asano A; Tsumita M; Suzuki Y; Shibata N
Jpn J Infect Dis; 2021 Sep; 74(5):473-476. PubMed ID: 33642429
[TBL] [Abstract][Full Text] [Related]
17. Lack of immunity against rubella among Italian young adults.
Gallone MS; Gallone MF; Larocca AMV; Germinario C; Tafuri S
BMC Infect Dis; 2017 Mar; 17(1):199. PubMed ID: 28270106
[TBL] [Abstract][Full Text] [Related]
18. Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program.
Ngaovithunvong V; Wanlapakorn N; Tesapirat L; Suratannon N; Poovorawan Y
J Infect Dev Ctries; 2016 Aug; 10(7):735-40. PubMed ID: 27482805
[TBL] [Abstract][Full Text] [Related]
19. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy.
Alleman MM; Wannemuehler KA; Hao L; Perelygina L; Icenogle JP; Vynnycky E; Fwamba F; Edidi S; Mulumba A; Sidibe K; Reef SE
Vaccine; 2016 Dec; 34(51):6502-6511. PubMed ID: 27866768
[TBL] [Abstract][Full Text] [Related]
20. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey.
Aksit S; Egemen A; Ozacar T; Kurugol Z; Keskinoglu P; Tasbakan M; Caglayan S
Pediatr Infect Dis J; 1999 Jul; 18(7):577-80. PubMed ID: 10440431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
